A meta-analysis published in 2019 on the prognostic significance of FGFR2 protein expression, which included 4294 patients with GC, primarily summarized data from the Japanese, South Korean, and Chinese patient cohorts (S4 Table) [28]. This evidence concerns the gene FGFR2 and gastric cancer.